Literature DB >> 8333553

Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis.

D Zagzag1, D C Miller, G M Kleinman, A Abati, H Donnenfeld, G N Budzilovich.   

Abstract

Clinical presentations as well as radiological and histopathological findings in biopsies from patients with multiple sclerosis (MS) or other demyelinating disorders of the central nervous system are sometimes misleading, resulting in an erroneous diagnosis of brain or spinal cord tumor. We report 17 patients who presented with symptoms mimicking those of brain (14 cases) or spinal cord (three cases) tumors. Computerized tomography or magnetic resonance imaging studies or both were interpreted as consistent with a tumor in each case. All patients underwent surgery, and all 17 pathological specimens were eventually diagnosed as showing demyelinating disease, usually consistent with MS. In each case we examined a variety of histological features and immunohistochemical studies and addressed their relative importance in considering the diagnosis of MS. All cases showed perivascular lymphocytic inflammation with variable amounts of macrophage infiltration, necrosis, and edema. The hypercellularity of the lesions and the presence of atypical reactive astrocytes with mitotic figures were the disturbing features that might have led to the erroneous diagnosis of an astrocytic neoplasm. Immunohistochemistry for astrocytic (glial fibrillary acidic protein) and macrophage (HAM-56) markers are helpful in evaluating biopsies. Our results emphasize the need to perform special stains (i.e., for myelin and axons) that demonstrate myelin loss and relative preservation of axons and allow a correct diagnosis.

Entities:  

Mesh:

Year:  1993        PMID: 8333553     DOI: 10.1097/00000478-199306000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

Review 1.  Non-neoplastic intramedullary pathology. Diagnostic dilemma: to Bx or not to Bx.

Authors:  T H Schwartz; P C McCormick
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.

Authors:  C H Toh; K-C Wei; S-H Ng; Y-L Wan; M Castillo; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 3.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

4.  Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.

Authors:  Fanny Burel-Vandenbos; Laurent Turchi; Maxime Benchetrit; Eric Fontas; Zoe Pedeutour; Valérie Rigau; Fabien Almairac; Damien Ambrosetti; Jean-François Michiels; Thierry Virolle
Journal:  Neuro Oncol       Date:  2013-08-09       Impact factor: 12.300

Review 5.  Perfusion CT imaging of brain tumors: an overview.

Authors:  R Jain
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

6.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

Authors:  S Cha; S Pierce; E A Knopp; G Johnson; C Yang; A Ton; A W Litt; D Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

7.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

Authors:  Rajan Jain; Shehanaz Ellika; Norman L Lehman; Lisa Scarpace; Lonni R Schultz; Jack P Rock; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-10-15       Impact factor: 4.130

9.  Intramedullary astrocytoma with granular cell differentiation.

Authors:  R Rodriguez y Baena; A Di Ieva; P Colombo; P Collini; P Navarria; M Scorsetti; P Gaetani; A Santoro
Journal:  Neurosurg Rev       Date:  2007-05-05       Impact factor: 3.042

10.  Intramedullary non-specific inflammatory lesion of thoracic spine: a case report.

Authors:  Alessandro Landi; Valerio Di Norcia; Demo Eugenio Dugoni; Roberto Tarantino; Martina Cappelletti; Manila Antonelli; Antonio Santoro; Roberto Delfini
Journal:  World J Surg Oncol       Date:  2010-01-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.